| 标题 |
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial |
| 网址 | |
| DOI |
10.1016/S0140-6736(18)31115-2
doi
|
| 其它 |
期刊:The Lancet 作者:Gerd R Burmester; Joel M. Kremer; Filip Van den Bosch; Alan Kivitz; Louis Bessette; et al 出版日期:2018-06-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)